This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.
Get full access to this article
View all access options for this article.
References
1.
DasCMendezGJagasiaSLabbateLA. Second-generation antipsychotic use in schizophrenia and associated weight gain: A critical review and meta-analysis of behavioral and pharmacologic treatments. Ann Clin Psychiatry. 2012;24(3):225–239.
2.
FiedorowiczJGMillerDDBishopJRCalargeCAEllingrodVLHaynesWG. Systematic review and meta-analysis of pharmacological interventions for weight gain from antipsychotics and mood stabilizers. Curr Psychiatry Rev. 2012;1;8(1):25–36.
3.
PraharajSKJanaAKGoyalNSinhaVK. Metformin for olanzapine-induced weight gain: A systematic review and meta-analysis. Br J Clin Pharmacol. 2011;71(3):377–382.
4.
WangMTongJHZhuGLiangGMYanHFWangXZ. Metformin for treatment of antipsychotic-induced weight gain: A randomized, placebo-controlled study. Schizophr Res. 2012;138(1):54–57.
5.
WuRRZhaoJPGuoXF. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: A double-blind, placebo-controlled study. Am J Psychiatry. 2008;165(3):352–358.
6.
BaptistaTRangelNFernándezV. Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: A multicentric, double-blind, placebo-controlled trial. Schizophr Res. 2007;93(1-3):99–108.
7.
WuRRJinHGaoK. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: A double-blind, randomized, placebo-controlled study. Am J Psychiatry. 2012;169(8):813–821.
8.
WuRRZhaoJPJinH. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA. 2008;299(2):185–193.
